Facebook Twitter LinkedIn
    Trending
    • As Ukraine effectively targets Russia's fleet – is bigger still better in the military?
    • Chancellor sets out stall to halt 'vicious circle' of tax hikes as pressure mounts
    • German media giant Axel Springer roars into £600m Telegraph auction
    • CM Pushkar Singh Dhami Shares Uttarakhand’s Growth Strategy After Returning From London
    • Fuel Bike vs Electric Bike: Confused? These top things can help you decide between the two
    • Four most important Patriots players in Week 4 matchup vs. Cowboys
    • Couple arrested on suspicion of attempting to sell jaguar cub in car park
    • Citizen eco-warriors armed with budget shed tech patrol sewage pollution frontline
    Facebook Twitter LinkedIn
    Business KhabarBusiness Khabar
    • World
    • Auto
    • Business
      • Industries
      • Opinion
    • Market
    • Money
      • Finance
      • Insurance
      • Investment
      • Schemes
    • Sports
    • Other
      • Stories
      • Career
      • Entrepreneurship
      • Property
    Business KhabarBusiness Khabar
    Health

    A pre-pandemic infection could explain why some patients develop long COVID

    ShehnazBy ShehnazSeptember 9, 2023No Comments
    A pre-pandemic infection could explain why some patients develop long COVID

    By Rick Sobey, Boston Herald

    A pre-pandemic frequent chilly coronavirus an infection could assist set the stage for lengthy COVID, in line with Boston researchers who’ve been trying to clarify why some sufferers find yourself going through the long-lasting, debilitating signs.

    The researchers from Brigham and Women’s Hospital and Massachusetts General Hospital teamed up with specialists in immunology and virology to search for clues about lengthy COVID in blood samples from sufferers with autoimmune rheumatic ailments.

    The workforce discovered that amongst these sufferers, those that developed lengthy COVID have been extra more likely to have expanded, pro-inflammatory antibodies particular to a coronavirus that causes the frequent chilly.

    An individual’s viral historical past, particularly prior an infection and enlargement of antibodies in opposition to a pre-pandemic coronavirus, might prime the immune system for creating lengthy COVID, in line with the researchers.

    “Our study offers evidence and explanation for why some of our patients may be experiencing the persistent and wide-ranging symptoms of long COVID,” mentioned co-corresponding creator Zachary Wallace, of the Division of Rheumatology, Immunology and Allergy at Massachusetts General Hospital.

    “Identifying a biomarker that helps us better understand current and previous infections could shed light on an inappropriate immune response that leads to some cases of long COVID,” Wallace added.

    Up to 45% of people with rheumatic ailments — which embody rheumatoid arthritis and different persistent autoimmune problems that trigger irritation — skilled persistent signs related to lengthy COVID 28 days after acute an infection with SARS-CoV-2.

    Patients with rheumatic ailments are additionally in danger for extra extreme illness and issues from acute an infection.

    Since the start of the pandemic, the Brigham and MGH researchers have paid particular consideration to this group of sufferers to assist with lengthy COVID therapies and care.

    The researchers in contrast immunological modifications in sufferers with rheumatic ailments who recovered from COVID. Specifically, they regarded for variations within the immunological fingerprints left behind by earlier infections.

    The workforce discovered an surprising sign tied to OC43, a coronavirus that causes frequent chilly signs. Individuals with lengthy COVID have been extra more likely to have antibody responses particular to this type of coronavirus.

    The examine is restricted to people with rheumatic ailments, and additional analysis is required to find out if their findings will apply extra extensively to sufferers with out a pre-existing autoimmune dysfunction.

    “By starting with patients with rheumatic diseases, we may be able to develop biomarkers that help us understand who is at high risk for developing long COVID and strategically enroll individuals into clinical trials to either prevent long COVID or develop therapies to treat it,” mentioned Wallace. “This study represents an important step in that direction.”

    Source: www.bostonherald.com”

    Shehnaz
    • Website
    • Twitter
    • LinkedIn

    Shehnaz is a Corporate Communications Expert by profession and writer by Passion. She has experience of many years in the same. Her educational background in Mass communication has given her a broad base from which to approach many topics. She enjoys writing about Public relations, Corporate communications, travel, entrepreneurship, insurance, and finance among others.

    Related Posts

    As COVID infections rise, nursing homes are still waiting for vaccines

    September 30, 2023

    Officials agree: Use settlement funds to curb youth addiction. But the ‘how’ gets hairy

    September 29, 2023

    Tim Wakefield, wife, both battling cancer: Red Sox

    September 29, 2023
    Facebook Twitter LinkedIn
    • About us
    • Contact
    • Contribute for us
    • Privacy Policy
    • Disclaimer
    © 2023 Business Khabar. Designed by ThemeSphere.

    Type above and press Enter to search. Press Esc to cancel.